(Q40875063)

24 September 2017

1 reference

title

New approaches to high-risk cervical cancer. Advanced cervical cancer (English)

1 reference

24 September 2017

main subject

cervix uterine cancer

1 reference

Jones WB

1

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

71

1 reference

24 September 2017

issue

4 Suppl

1 reference

24 September 2017

page(s)

1451-1459

1 reference

24 September 2017

cites work

Cancer statistics, 1992

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

The role of cervical cytology in the declining morbidity and mortality of cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

The relationship of cervical cytology to the incidence of invasive cervical cancer and mortality in Alameda County, California, 1960 to 1974

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Cancer of the cervix and screening.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Surgical approaches for advanced or recurrent cancer of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Patterns of failure of bulky-barrel carcinomas of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Prognostic factors and operative treatment of stages IB to IIB cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

The outcome of the patients with recurrent cervical carcinoma in terms of lymph node metastasis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Screening for cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

A possible new trend in the management of the carcinoma of the cervix uteri

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Comparative study of intravenous and intraarterial cis-platinum on intratumoral platinum concentration in carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Primary chemotherapy and postoperative adjuvant chemotherapy in the treatment of squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Complete response to pre-operative chemotherapy in stage III B cervical carcinoma. Case report.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Induction chemotherapy followed by radical surgery in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Pelvic lymph node metastasis of uterine cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Lymph node positivity in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential Panel at the 1979

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Cancer of uterine cervix stage IB. Treatment results and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Individualization of patients for adjuvant chemotherapy after surgical treatment of cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710408

7 January 2021

Identifiers

DOI

10.1002/CNCR.2820710408

0 references

1 reference